Clinical Trial

Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2020 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.
Summary
This study is an observation, single center study to evaluate the alternations and prognostic value of peripheral blood lymphocyte (PBL) in patients diagnosed with thoracic cancers, including lung cancer, esophageal squamous cell carcinoma and thymic epithelial carcinoma underwent radiotherapy with or without chemotherapy.
Trial Details
NCT Number NCT04522687
Lead Sponsor Shanghai Cancer Hospital, China
Conditions NSCLC, Esophageal Squamous Cell Carcinoma, Thymic Epithelial Tumor
Enrollment 500 participants
Start Date 2012-01-01
Primary Completion 2023-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2020-08-21